DR.WU Skincare Co., Ltd. · TPEX:6523
DR.WU Skincare — Investor Conference hosted by SinoPac Securities (September 2022)
14 slides from DR.WU Skincare's conference presentation, Sep 21, 2022
Slide 1: DR. WU Skincare Co., Ltd Investor Meeting
DR. WU Skincare Co., Ltd Investor Meeting 2022.09.21
Slide 2: Disclaimer
Disclaimer • The information and forecast contained in this presentation and released at the same time, including the information regarding business outlook, financial status, and business forecast, is produced according to the internal data of this Company and the status of overall macroeconomic de
Slide 3: Agenda
01 Introduction to DR.WU Skincare Agenda 02 2022 1H Financial Performance
Slide 4: Introduction to DR.WU Skincare
01 Introduction to DR.WU Skincare
Slide 5: Company Introduction: Quick Facts about Us
Company Introduction Quick Facts about Us • Founded:2003 • Co-Founders: Dr. Wu & Eric Wu • Listing on TPEX:2016 • Market Capital:TWD 4.5 billion (Sep.2022) • Revenue: TWD 1.1 billion (FY21) • Product: 10 Skin Care Lines • Sales Channel:8 Countries • Employee:110 staffs
Slide 6: Asia's Leading Derma Skincare: Our Milestones
Asia’s Leading Derma Skincare Our Milestones Product Expansion to DR.WU Officially Beauty Supplements Incepted No 2. Hero Product New Premium Brand Intensive Renewal Serum No 4. Hero Product Launched - Redermx with Mandelic Acid Glutalight Intensive No1. Hero Product Whitening Serum Intensive Hydrat
Slide 7: Our Philosophy & Mission
Company Introduction Our Philosophy & Mission Asia’s Leading Derma Skincare ✓ DR.WU is a line of highly effective skincare products developed with advanced patented technologies to target various problems in Asian skins. ✓ Our philosophy behind our pursuit for enhancing beauty and wellness is throug
Slide 8: Continue To Enhance ESG and Sustainability
Continue To Enhance ESG and Sustainability Environmental Support Advocate Diversity Friendly Communities & Well-being • Almost 90% Already Recyclable • Supported Burn Survivors • More Than 90% of Employees Packaging • Advocated Anti-violence Campaign Identify as Female • Replaced 500K plastic-made t
Slide 9: 2022 1H Financial Results
DR.WU 2022 1H Financial Results
Slide 10: DR.WU Financial Performance
DR.WU Financial Performance Maintained Momentum with Improved Profitability Revenue Breakdown by Channels Margins 1H22 Channel 1H21 1H22 YoY Contribution 69% 70% 69% Physical Taiwan 215,873 234,380 9% 55% 61% 63% 58% Online Taiwan 122,948 134,969 10% 32% 44% 38% 37% Taiwan subtotal 338,821 369,349 9
Slide 11: Historical Dividend Payout
Historical Dividend Payout - Average Cash Dividend Payout Ratio > 90% NTD - Issued by quarterly basis since 2021 2016-2Q22 EPS & Cash Dividends 14.68 15.22** 14.0 * EPS Cash dividend 7.06 6.60 6.58 4.26 3.86 2.78 2.50 2.46 2.0 2.0 0.55 0.5 1.17 2016 2017 2018 2019 2020 2021 1Q22 2Q22 * NT$10 cash di
Slide 12: Consolidate Income Statement
Consolidate Income Statement NT$ ‘000 2Q21 2Q22 1H21 1H22 Consolidate YoY% YoY% Amount % Amount % Amount % Amount % Net Revenue 235,260 100.0% 165,799 100.0% -29.5% 472,820 100.0% 423,224 100.0% -10.5% Operating Costs 98,421 41.8% 52,558 31.7% 172,030 36.4% 129,967 30.7% Gross Profit 136,839 58.2% 1
Slide 13: Balance Sheet & Key Indices
Balance Sheet & Key Indices NT$ ‘000 Selected Items 2021.06.30 % 2022.03.31 % 2022.06.30 % Cash and Cash Equivalents 628,986 29% 851,673 46% 638,548 35% Financial Assets at Amortized Cost 772,200 35% 567,300 30% 822,900 45% Accounts Receivable 171,156 8% 186,267 10% 83,546 5% Inventories 131,429 6%
Slide 14: Thank you
Thank you Contact Information Cheryl Lin, Investor Relations TEL:+886-2-2517-9888 E-mail:[email protected]
DR. WU Skincare — Investor Conference hosted by SinoPac Securities (September 2022) on 6ix